Jun 22, 2026Final prospectus0001213900-26-070622
All companies
Trade Lakewood Amedex Biotherapeutics Inc
Lakewood Amedex Biotherapeutics Inc
LABTPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $5.47M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
LABTPrice
$2.31
24h
+4.05%
Valuation
$5.47M
24h volume
$102.51K
Type
IPO
Trade Lakewood Amedex Biotherapeutics IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
About Lakewood Amedex Biotherapeutics Inc
Lakewood Amedex Biotherapeutics Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Lakewood Amedex Biotherapeutics Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
Final prospectusEDGAR filings resolved from LABT / CIK 0002079272.
Jun 22, 2026Final prospectus0001213900-26-070620
May 26, 2026Final prospectus0001213900-26-061019
May 26, 2026Final prospectus0001213900-26-061018
424B4PROSPECTUS
May 14, 2026Final prospectus0001213900-26-056648
May 13, 2026Effective9999999995-26-001622
CORRESPfilename1.htm
May 12, 2026SEC correspondence0001213900-26-054931
UPLOADfilename1.pdf
May 8, 2026SEC correspondence0000000000-26-004726
May 1, 2026Filed0001213900-26-050936
Apr 30, 2026Final prospectus0001213900-26-050264
424B4PROSPECTUS
Apr 23, 2026Final prospectus0001213900-26-047113
Apr 22, 2026Exchange registration0001354457-26-000363
Lakewood Amedex Biotherapeutics Inc IPO — frequently asked questions
- When did Lakewood Amedex Biotherapeutics Inc go public?
- Lakewood Amedex Biotherapeutics Inc has already gone public and now trades publicly on Nasdaq under the ticker LABT.
- Can I buy Lakewood Amedex Biotherapeutics Inc stock?
- Yes — Lakewood Amedex Biotherapeutics Inc is publicly traded on Nasdaq as LABT. You can follow its live price, valuation and post-IPO performance above.
- What is Lakewood Amedex Biotherapeutics Inc's valuation?
- Lakewood Amedex Biotherapeutics Inc's most recent valuation tracked here is $5.47M, derived from live market prices.